Rossetti, A.C.; Paladini, M.S.; Brüning, C.A.; Spero, V.; Cattaneo, M.G.; Racagni, G.; Papp, M.; Riva, M.A.; Molteni, R.
Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression. Int. J. Mol. Sci. 2022, 23, 12453.
https://doi.org/10.3390/ijms232012453
AMA Style
Rossetti AC, Paladini MS, Brüning CA, Spero V, Cattaneo MG, Racagni G, Papp M, Riva MA, Molteni R.
Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression. International Journal of Molecular Sciences. 2022; 23(20):12453.
https://doi.org/10.3390/ijms232012453
Chicago/Turabian Style
Rossetti, Andrea C., Maria Serena Paladini, Cesar Augusto Brüning, Vittoria Spero, Maria Grazia Cattaneo, Giorgio Racagni, Mariusz Papp, Marco A. Riva, and Raffaella Molteni.
2022. "Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression" International Journal of Molecular Sciences 23, no. 20: 12453.
https://doi.org/10.3390/ijms232012453
APA Style
Rossetti, A. C., Paladini, M. S., Brüning, C. A., Spero, V., Cattaneo, M. G., Racagni, G., Papp, M., Riva, M. A., & Molteni, R.
(2022). Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression. International Journal of Molecular Sciences, 23(20), 12453.
https://doi.org/10.3390/ijms232012453
